Citations (227)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Federica Giachero, Andreas Jenke & Matthias Zilbauer. (2021) Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine. Expert Review of Clinical Immunology 17:8, pages 871-881.
Read now
Read now
Bing-xia Chen, Ze-min Han, Qian Zhou, Hong-bin Liu, Pei-chun Xu & Fa-chao Zhi. (2021) Efficacy of infliximab in treatment-naïve patients with stricturing small bowel Crohn’s disease. Scandinavian Journal of Gastroenterology 56:7, pages 812-819.
Read now
Read now
Mohamed Attauabi, Johan Burisch & Jakob Benedict Seidelin. (2021) Efficacy of ustekinumab for active perianal fistulizing Crohn’s disease: a systematic review and meta-analysis of the current literature. Scandinavian Journal of Gastroenterology 56:1, pages 53-58.
Read now
Read now
Carla Carnovale, Anna Maffioli, Gloria Zaffaroni, Faizan Mazhar, Vera Battini, Giulia Mosini, Marco Pozzi, Sonia Radice, Emilio Clementi & Piergiorgio Danelli. (2020) Efficacy of Tumour Necrosis Factor-alpha therapy in paediatric Crohn’s disease patients with perianal lesions: a systematic review. Expert Opinion on Biological Therapy 20:3, pages 239-251.
Read now
Read now
Cátia Arieira, Tiago Cúrdia Gonçaves, Francisca Dias de Castro, Maria João Moreira & José Cotter. (2018) Clinical course in Crohn’s disease: factors associated with behaviour change and surgery. Scandinavian Journal of Gastroenterology 53:10-11, pages 1222-1227.
Read now
Read now
C. Reenaers, C. Pirard, C. Vankemseke, P. Latour, J. Belaiche & E. Louis. (2016) Long-term evolution and predictive factors of mild inflammatory bowel disease. Scandinavian Journal of Gastroenterology 51:6, pages 712-719.
Read now
Read now
Morten H. Vatn & Arne K. Sandvik. (2015) Inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:6, pages 748-762.
Read now
Read now
Robert V Bryant, Oliver Brain & Simon P.L. Travis. (2015) Conventional drug therapy for inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:1, pages 90-112.
Read now
Read now
Ashwin N Ananthakrishnan. (2013) Personalizing therapy for inflammatory bowel diseases. Expert Review of Gastroenterology & Hepatology 7:6, pages 549-558.
Read now
Read now
Pal Miheller, Lajos S Kiss, Mark Juhasz, Michael Mandel & Peter L Lakatos. (2013) Recommendations for identifying Crohn’s disease patients with poor prognosis. Expert Review of Clinical Immunology 9:1, pages 65-76.
Read now
Read now
David T. Rubin, Remo Panaccione, Jingdong Chao & Anne M. Robinson. (2011) A practical, evidence-based guide to the use of adalimumab in Crohn’s disease. Current Medical Research and Opinion 27:9, pages 1803-1813.
Read now
Read now
Tim W Eglinton & Richard B Gearry. (2010) Clinical factors predicting disease course in Crohn’s disease. Expert Review of Clinical Immunology 6:1, pages 41-45.
Read now
Read now
Joanna M Hunter & Eustache Paramithiotis. (2010) Protein biomarker quantification by mass spectrometry. Expert Opinion on Medical Diagnostics 4:1, pages 11-20.
Read now
Read now
Raja GR Edula & Michael F Picco. (2009) An evidence-based review of natalizumab therapy in the management of Crohn’s disease. Therapeutics and Clinical Risk Management 5, pages 935-942.
Read now
Read now
G.R. D’Haens. (2009) TOP-DOWN THERAPY FOR CROHN’S DISEASE : RATIONALE AND EVIDENCE. Acta Clinica Belgica 64:6, pages 540-546.
Read now
Read now
Helge L. Waldum. (2008) August issue of Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 43:8, pages 899-901.
Read now
Read now
Articles from other publishers (211)
Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon & Jihye Park. (2023) Impact of age at diagnosis on long‐term prognosis in patients with intestinal Behçet's disease. Journal of Gastroenterology and Hepatology 39:3, pages 519-526.
Crossref
Crossref
Can Wang, Fan Yang, Lichao Qiao, Xiaoxiao Wang, Qi Chen, Hongjin Chen, Yi Li, Xiaoqi Zhang, Xiujun Liao, Lei Cao, Haixia Xu, Yu Xiang & Bolin Yang. (2024) Monitoring-Based Model for Personalizing Fecal Incontinence in Patients With Crohn’s Disease: A Multicenter Inception Cohort Study. Inflammatory Bowel Diseases.
Crossref
Crossref
Kohei Ogasawara, Hiroto Hiraga, Yoshihiro Sasaki, Noriko Hiraga, Naoki Higuchi, Keisuke Hasui, Shinji Ota, Takato Maeda, Yasuhisa Murai, Tetsuya Tatsuta, Hidezumi Kikuchi, Daisuke Chinda, Tatsuya Mikami, Masashi Matsuzaka, Hirotake Sakuraba & Shinsaku Fukuda. (2023) A Logistic Regression Model for Predicting the Risk of Subsequent Surgery among Patients with Newly Diagnosed Crohn’s Disease Using a Brute Force Method. Diagnostics 13:23, pages 3587.
Crossref
Crossref
E. G. Ganich & O. B. Shchukina. (2023) Features of Crohn's Disease Depending on the Age of Disease Onset. Russian Journal of Gastroenterology, Hepatology, Coloproctology 33:5, pages 65-77.
Crossref
Crossref
Arash Assadsangabi, Caroline A Evans, Bernard M Corfe & Alan J Lobo. (2023) Exploring Predictive Biomarkers of Relapse in Ulcerative Colitis: A Proteomics Approach. Inflammatory Bowel Diseases.
Crossref
Crossref
Zhen Zeng, Mingshan Jiang, Xi Li, Jing Yuan & Hu Zhang. (2023) Precision medicine in inflammatory bowel disease. Precision Clinical Medicine 6:4.
Crossref
Crossref
Yury A. Shelygin, Vladimir T. IvashkinSergey I. Achkasov, Igor V. ReshetovIgor V. Maev, Elena A. Belousova, Armen V. Vardanyan, Bella A. Nanaeva, Leila V. Adamyan, Oksana M. Drapkina, Leila S. Namazova-Baranova, Aleksandr Yu. RazumovskyAmiran Sh. Revishvili, Igor E. Khatkov, Aleksey V. Shabunin, Maria A. Livzan, Aleksandr V. SazhinVil M. Timerbulatov, Olga V. Khlynova, Diana I. Abdulganieva, Rustem A. Abdulkhakov, Timofey L. Aleksandrov, Olga P. Alekseeva, Sergey A. Alekseenko, Ivan S. Anosov, Igor G. Bakulin, Olga Yu. Barysheva, Kirill V. BolikhovViktor V. Veselov, Oleg V. Golovenko, Irina V. Gubonina, Anastasia I. Dolgushina, Tatiana N. Zhigalova, Anna V. Kagramanova, Vladimir N. Kashnikov, Oleg V. Knyazev, Nikolay V. Kostenko, Aleksey A. Likutov, Ekaterina Y. Lomakina, Irina D. Loranskaya, Airat F. Mingazov, Aleksey I. Moskalev, Ilya V. Nazarov, Natalia V. Nikitina, Alfia H. Odintsova, Vitaly V. Omelyanovsky, Marina F. Osipenko, Аndrey V. Оshchepkov, Vladimir V. Pavlenko, Elena A. PoluektovaGrigory V. RodomanAnastasia M. Segal, Stanislav I. Sitkin, Maria I. Skalinskaya, Andrey N. Surkov, Oleg I. Sushkov, Larisa V. Tarasova, Yulia B. UspenskayaSergey A. Frolov, Elena Yu. Chashkova, Oleg S. ShifrinOlga V. ShcherbakovaOksana B. Shchukina, Tatiana V. Shkurko & P. A. Makarchuk. (2023) Clinical guidelines. Crohn’s disease (К50), adults. Koloproktologia 22:3, pages 10-49.
Crossref
Crossref
Tommaso Lorenzo Parigi, Ferdinando D'Amico, Maria T Abreu, Axel Dignass, Iris Dotan, Fernando Magro, Anne M Griffiths, Vipul Jairath, Marietta Iacucci, Gerassimos J Mantzaris, Colm O'Morain, Walter Reinisch, David B Sachar, Dan Turner, Takayuki Yamamoto, David T Rubin, Laurent Peyrin-Biroulet, Subrata Ghosh & Silvio Danese. (2023) Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting. The Lancet Gastroenterology & Hepatology 8:9, pages 853-859.
Crossref
Crossref
Małgorzata Godala, Ewelina Gaszyńska, Konrad Walczak & Ewa Małecka-Wojciesko. (2023) Evaluation of Albumin, Transferrin and Transthyretin in Inflammatory Bowel Disease Patients as Disease Activity and Nutritional Status Biomarkers. Nutrients 15:15, pages 3479.
Crossref
Crossref
Alyssa M. Parian, Ling Li, Leonardo C. Duraes, Jiafei Cheng, Haijie Hu, Zhicheng Yao, Jean Donet, George Salem, Alina Iuga, Kevan Salimian, Jessica Izzi, Atif Zaheer, Hai-Quan Mao, Susan Gearhart & Florin M. Selaru. (2022) A Novel Patient-like Swine Model of Perianal Crohn’s Disease. Diseases of the Colon & Rectum 66:3, pages 425-433.
Crossref
Crossref
James Irwin, Anton Lord, Emma Ferguson, Lisa A. Simms, Katherine Hanigan, Carlos A. Montoya & Graham Radford-Smith. (2022) A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn’s Disease. Digestive Diseases and Sciences 68:2, pages 596-607.
Crossref
Crossref
Kyunghwan Oh, Hee Seung Hong, Nam Seok Ham, Jungbok Lee, Sang Hyoung Park, Suk-Kyun Yang, Hyuk Yoon, You Sun Kim, Chang Hwan Choi & Byong Duk Ye. (2023) Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn’s disease: a KASID prospective multicenter study. Intestinal Research 21:1, pages 137-147.
Crossref
Crossref
Sophie Vieujean & Edouard Louis. (2023) Precision medicine and drug optimization in adult inflammatory bowel disease patients. Therapeutic Advances in Gastroenterology 16, pages 175628482311733.
Crossref
Crossref
Guillermo Bastida Paz, Olga Merino Ochoa, Mariam Aguas Peris, Manuel Barreiro-de Acosta, Yamile Zabana, Daniel Ginard Vicens, Daniel Ceballos Santos, Fernando Muñoz Núñez, David Monfort i Miquel, Ignacio Catalán-Serra, Valle García Sánchez, Carmen Loras Alastruey, Alfredo Lucendo Villarín, Jose Maria Huguet, Cristóbal de la Coba Ortiz, Xavier Aldeguer Manté, Antonio Palau Canós, Eugeni Domènech Morral & Pilar Nos. (2023) The Risk of Developing Disabling Crohn’s Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision Making. Digestive Diseases 41:6, pages 879-889.
Crossref
Crossref
Stephan Brand. 2023. Pflege bei chronisch-entzündlichen Darmerkrankungen. Pflege bei chronisch-entzündlichen Darmerkrankungen
43
69
.
Carolina da Silva Beda Sacramento, Marina Pamponet Motta, Candida de Oliveira Alves, Jaciane Araujo Mota, Lina Maria Goes de Codes, Reginaldo Freitas Ferreira, Pedro de Almeida Silva, Larissa do Prado Palmiro, Rafael Miranda Barbosa, Mariana Nery Andrade, Vitor Damasceno Andrade, Vitor Brandão Vasconcelos, Bernardo Wasconcellos Thiara, Eduardo Martins Netto & Genoile Oliveira Santana. (2022) Variables associated with progression of moderate-to-severe Crohn’s disease. BMJ Open Gastroenterology 9:1, pages e001016.
Crossref
Crossref
Marie-Laure Rabilloud, Emma Bajeux, Laurent Siproudhis, Stéphanie Hamonic, Maël Pagenault, Charlène Brochard, Agathe Gerfaud, Alain Dabadie, Jean-François Viel, Isabelle Tron, Michel Robaszkiewicz, Jean-François Bretagne & Guillaume Bouguen. (2022) Long-term outcomes and predictors of disabling disease in a population-based cohort of patients with incident Crohn's disease diagnosed between 1994 and 1997. Clinics and Research in Hepatology and Gastroenterology 46:9, pages 101974.
Crossref
Crossref
Shankar Kumar, Andrew Plumb, Sue Mallett, Gauraang Bhatnagar, Stuart Bloom, Caroline S Clarke, John Hamlin, Ailsa L Hart, Ilan Jacobs, Simon Travis, Roser Vega, Steve Halligan & Stuart Andrew Taylor. (2022) METRIC-EF: magnetic resonance enterography to predict disabling disease in newly diagnosed Crohn’s disease—protocol for a multicentre, non-randomised, single-arm, prospective study. BMJ Open 12:10, pages e067265.
Crossref
Crossref
Su Hyun Park & Sang Hyoung Park. (2022) Personalized medicine in inflammatory bowel disease: Perspectives on Asia. Journal of Gastroenterology and Hepatology 37:8, pages 1434-1445.
Crossref
Crossref
Jan Marsal, Manuel Barreiro-de Acosta, Irina Blumenstein, Maria Cappello, Thomas Bazin & Shaji Sebastian. (2022) Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. Frontiers in Medicine 9.
Crossref
Crossref
Bram Verstockt, Miles Parkes & James C. Lee. (2022) How Do We Predict a Patient’s Disease Course and Whether They Will Respond to Specific Treatments?. Gastroenterology 162:5, pages 1383-1395.
Crossref
Crossref
Christopher A. Lamb, Aamir Saifuddin, Nick Powell & Florian Rieder. (2022) The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease. Gastroenterology 162:5, pages 1525-1542.
Crossref
Crossref
Lindsey S Lawrence, Amer Heider, Andrew A M Singer, Haley C Neef & Jeremy Adler. (2022) Granulomas in Diagnostic Biopsies Associated With High Risk of Crohn’s Complications—But May Be Preventable. Inflammatory Bowel Diseases 28:4, pages 523-530.
Crossref
Crossref
Choong Wui Cho, Myung-Won You, Chi Hyuk Oh, Chang Kyun Lee & Sung Kyoung Moon. (2022) Long-term Disease Course of Crohn’s Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors. Gut and Liver 16:2, pages 157-170.
Crossref
Crossref
Silvia D’Alessio, Federica Ungaro, Daniele Noviello, Sara Lovisa, Laurent Peyrin-Biroulet & Silvio Danese. (2021) Revisiting fibrosis in inflammatory bowel disease: the gut thickens. Nature Reviews Gastroenterology & Hepatology 19:3, pages 169-184.
Crossref
Crossref
Fernando Magro, Catarina Sottomayor, Catarina Alves, Mafalda Santiago, Paula Ministro, Paula Lago, Luís Correia, Raquel Gonçalves, Diana Carvalho, Francisco Portela, Cláudia Camila Dias, Axel Dignass, Silvio Danese, Laurent Peyrin-Biroulet, Maria Manuela Estevinho & Paula Leão Moreira. (2022) Composite outcomes in observational studies of Crohn’s disease: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 15, pages 175628482210927.
Crossref
Crossref
Parul Tandon & Adam V. Weizman. 2022. Management of Inpatient Inflammatory Bowel Disease. Management of Inpatient Inflammatory Bowel Disease
91
108
.
Haichao Wang, Yaling Wu, Chen Ye, Zhanju Liu & Xiaolei Wang. (2021) Perianal disease onset age is associated with distinct disease features and need for intestinal resection in perianal Crohn’s disease: a ten-year hospital-based observational study in China. BMC Gastroenterology 21:1.
Crossref
Crossref
M. A. Niriella, I. K. Liyanage, S. K. Kodisinghe, A. P. De Silva, A. V. G. A. M. Jayatissa, N. M. M. Navarathne, R. K. Peiris, U. P. Kalubovila, S. R. Kumarasena, R. W. Jayasekara & H. J. de Silva. (2021) Changing phenotype, early clinical course and clinical predictors of inflammatory bowel disease in Sri Lanka: a retrospective, tertiary care-based, multi-centre study. BMC Gastroenterology 21:1.
Crossref
Crossref
Tim Raine, Bram Verstockt, Uri Kopylov, Konstantinos Karmiris, Rimma Goldberg, Raja Atreya, Johan Burisch, John Burke, Pierre Ellul, Charlotte Hedin, Stefan D Holubar, Konstantinos Katsanos, Triana Lobaton, Carsten Schmidt & Garret Cullen. (2021) ECCO Topical Review: Refractory Inflammatory Bowel Disease. Journal of Crohn's and Colitis 15:10, pages 1605-1620.
Crossref
Crossref
Hanna Blaney, Peter Vu, Antony Mathew, Robin Snelling, Julie England, Camille Duong, Kendall Hammonds & Christopher Johnson. (2020) Anemia Severity Associated with Increased Healthcare Utilization and Costs in Inflammatory Bowel Disease. Digestive Diseases and Sciences 66:8, pages 2555-2563.
Crossref
Crossref
Steve Halligan, Darren Boone, Lucinda Archer, Tariq Ahmad, Stuart Bloom, Manuel Rodriguez-Justo, Stuart A Taylor & Sue Mallett. (2021) Prognostic biomarkers to identify patients likely to develop severe Crohn’s disease: a systematic review. Health Technology Assessment 25:45, pages 1-66.
Crossref
Crossref
Beatriz Sicilia, Lara Arias, Gadea Hontoria, Nieves García, Ester Badia & Fernando Gomollón. (2021) Are Steroids Still Useful in Immunosuppressed Patients With Inflammatory Bowel Disease? A Retrospective, Population-Based Study. Frontiers in Medicine 8.
Crossref
Crossref
Eun Mi Song, Ho‐Su Lee, Ye‐Jee Kim, Eun Hye Oh, Nam Seok Ham, Jeongseok Kim, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Byong Duk Ye, Jeong‐Sik Byeon, Seung‐Jae Myung & Suk‐Kyun Yang. (2020) Clinical outcomes and long‐term prognosis of perianal Crohn's disease in an Asian population. Journal of Gastroenterology and Hepatology 36:6, pages 1571-1579.
Crossref
Crossref
. (2021) Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing). Journal of Digestive Diseases 22:6, pages 298-317.
Crossref
Crossref
Eisuke Takeyama, Hiroo Wada, Setsuko Sato, Kiyohide Tomooka, Ai Ikeda & Takeshi Tanigawa. (2021) Association of diagnostic delay with medical cost for patients with Crohn's disease: A Japanese claims‐based cohort study. JGH Open 5:5, pages 568-572.
Crossref
Crossref
Danny Con, Nina Parthasarathy, Maria Bishara, Raphael P Luber, Neetima Joshi, Anna Wan, James A Rickard, Tony Long, Declan J Connoley, Miles P Sparrow, Peter R Gibson, Daniel R van Langenberg & Abhinav Vasudevan. (2021) Development of a Simple, Serum Biomarker-based Model Predictive of the Need for Early Biologic Therapy in Crohn’s Disease. Journal of Crohn's and Colitis 15:4, pages 583-593.
Crossref
Crossref
A. V. Nikitin & G. V. Volynets. (2021) Sclerosing cholangitis and inflammatory bowel disease: which comes first?. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 66:1, pages 39-46.
Crossref
Crossref
Paula MinistroCláudia Camila DiasFrancisco PortelaSamuel FernandesSónia BernardoFrancisco PiresPaula LagoIsadora RosaEunice TrindadeCatarina AlvesLuís CorreiaFernando Magro. (2021) Age at Diagnosis Is Determinant for the Outcome of Inflammatory Bowel Disease: Is It a Myth?. Clinical and Translational Gastroenterology 12:2, pages e00309.
Crossref
Crossref
Pier Paolo Mainenti, Fabiana Castiglione, Antonio Rispo, Ettore Laccetti, Salvatore Guarino, Valeria Romeo, Anna Testa, Leonardo Pace & Simone Maurea. (2021) MR-enterography in Crohn’s disease: what MRE mural parameters are associated to one-year therapeutic management outcome?. The British Journal of Radiology 94:1118, pages 20200844.
Crossref
Crossref
Satoshi Tamura, Natsuki Ishida, Takahiro Miyazu, Shunya Onoue, Shinya Tani, Mihoko Yamade, Yasushi Hamaya, Moriya Iwaizumi, Satoshi Osawa, Takahisa Furuta & Ken Sugimoto. (2020) Mesalazine granule formulation improves clinical data in Crohn's disease compared with tablet formulation. Scientific Reports 10:1.
Crossref
Crossref
Hajar Halawani, Ahmed Abduljabbar, Mohammad Wazzan, Dalia Hashem, Cedric Baumann, Amandine LUC, Laurent Peyrin-Biroulet, Omar I Saadah & Mahmoud Mosli. (2020) Bowel Damage at Diagnosis Using the Lémann Index Score in Saudi Arabian Patients With Crohn's Disease. Cureus.
Crossref
Crossref
Jean A Donet, Aline Charabaty & Alan C Moss. (2020) Management of Asymptomatic Terminal Ileitis. Crohn's & Colitis 360 2:4.
Crossref
Crossref
J.C. Andreu-Ballester, I. Catalán-Serra, R. Gil-Borrás, P. Marqués-García, C. García-Ballesteros, F. López Chuliá & C. Cuéllar. (2020) Gammadelta T cells as a predictor of surgical relapse of Crohn's disease. Clinics and Research in Hepatology and Gastroenterology 44:4, pages 586-597.
Crossref
Crossref
Article Editorial. (2020) CROHN'S DISEASE. CLINICAL RECOMMENDATIONS (PRELIMINARY VERSION). Koloproktologia 19:2, pages 8-38.
Crossref
Crossref
Hunter Bratton, Mohammad Alomari, Laith Al Momani, Pravallika Chadalavada, Fahrettin Covut, May Olayan & Mark Young. (2020) Etiology of and predictive factors for chronic intestinal failure requiring long term parenteral support in the last two decades: A retrospective study. Clinical Nutrition ESPEN 37, pages 168-172.
Crossref
Crossref
Giulia Roda, Siew Chien Ng, Paulo Gustavo Kotze, Marjorie Argollo, Remo Panaccione, Antonino Spinelli, Arthur Kaser, Laurent Peyrin-Biroulet & Silvio Danese. (2020) Crohn’s disease. Nature Reviews Disease Primers 6:1.
Crossref
Crossref
Thomas Chateau & Laurent Peyrin‐Biroulet. (2020) Evolving therapeutic goals in Crohn's disease management. United European Gastroenterology Journal 8:2, pages 133-139.
Crossref
Crossref
Jia-Yin Yao, Yi Jiang, Jia Ke, Yi Lu, Jun Hu & Min Zhi. (2020) Development of a prognostic model for one-year surgery risk in Crohn’s disease patients: A retrospective study. World Journal of Gastroenterology 26:5, pages 524-534.
Crossref
Crossref
Jonathan A. Beard, Diana L. Franco & Benjamin H. Click. (2020) The Burden of Cost in Inflammatory Bowel Disease: A Medical Economic Perspective and the Future of Value-Based Care. Current Gastroenterology Reports 22:2.
Crossref
Crossref
Simon P. Borg-Bartolo, Ray Kiran Boyapati, Jack Satsangi & Rahul Kalla. (2020) Precision medicine in inflammatory bowel disease: concept, progress and challenges. F1000Research 9, pages 54.
Crossref
Crossref
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy Sanderson, Helen Terry, Daniel R Gaya, Tariq H Iqbal, Stuart A Taylor, Melissa Smith, Matthew Brookes, Richard Hansen & A Barney Hawthorne. (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68:Suppl 3, pages s1-s106.
Crossref
Crossref
S. Fischer & M. F. Neurath. (2019) Leitliniengerechte Therapie des Morbus CrohnGuideline-based therapy of Crohn’s disease. Der Gastroenterologe 14:6, pages 423-430.
Crossref
Crossref
Samantha Webster. (2019) Defining the Future of Inflammatory Bowel Disease Care: The Pivotal Role of Personalised Treatment. EMJ Gastroenterology, pages 2-10.
Crossref
Crossref
Yusuf Kayar, Bulent Baran, Asli Cifcibasi Ormeci, Filiz Akyuz, Kadir Demir, Fatih Besisik & Sabahattin Kaymakoglu. (2019) Risk factors associated with progression to intestinal complications of Crohn disease. Chinese Medical Journal 132:20, pages 2423-2429.
Crossref
Crossref
Andreas Stallmach, Bernd Bokemeyer, Ulf Helwig, Andreas Lügering, Niels Teich, Imma Fischer, Stefan Rath, Dorothee Lang & Carsten Schmidt. (2019) Predictive parameters for the clinical course of Crohn’s disease: development of a simple and reliable risk model. International Journal of Colorectal Disease 34:10, pages 1653-1660.
Crossref
Crossref
Sarah O’Donnell, Krzysztof Borowski, Osvaldo Espin-Garcia, Raquel Milgrom, Boyko Kabakchiev, Joanne Stempak, Deepah Panikkath, Bertus Eksteen, Wei Xu, A Hillary Steinhart, Gilaad G Kaplan, Dermot P B McGovern & Mark S Silverberg. (2019) The Unsolved Link of Genetic Markers and Crohn’s Disease Progression: A North American Cohort Experience. Inflammatory Bowel Diseases 25:9, pages 1541-1549.
Crossref
Crossref
Remo Panaccione, A. Hillary Steinhart, Brian Bressler, Reena Khanna, John K. Marshall, Laura Targownik, Waqqas Afif, Alain Bitton, Mark Borgaonkar, Usha Chauhan, Brendan Halloran, Jennifer Jones, Erin Kennedy, Grigorios I. Leontiadis, Edward V. LoftusJr.Jr., Jonathan Meddings, Paul Moayyedi, Sanjay Murthy, Sophie Plamondon, Greg Rosenfeld, David Schwartz, Cynthia H. Seow, Chadwick Williams & Charles N. Bernstein. (2019) Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease. Clinical Gastroenterology and Hepatology 17:9, pages 1680-1713.
Crossref
Crossref
Remo Panaccione, A Hillary Steinhart, Brian Bressler, Reena Khanna, John K Marshall, Laura Targownik, Waqqas Afif, Alain Bitton, Mark Borgaonkar, Usha Chauhan, Brendan Halloran, Jennifer Jones, Erin Kennedy, Grigorios I Leontiadis, Edward V LoftusJrJr, Jonathan Meddings, Paul Moayyedi, Sanjay Murthy, Sophie Plamondon, Greg Rosenfeld, David Schwartz, Cynthia H Seow, Chadwick Williams & Charles N Bernstein. (2019) Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn’s Disease. Journal of the Canadian Association of Gastroenterology 2:3, pages e1-e34.
Crossref
Crossref
Jimil Shah, Manik Lal Thakur & Usha Dutta. (2019) Mucosal healing in inflammatory bowel disease: Expanding horizon. Indian Journal of Gastroenterology 38:2, pages 98-109.
Crossref
Crossref
Shanshan HuangLi LiShomron Ben-HorinRen MaoSinan LinYun QiuRui FengYao HeBaili ChenZhirong ZengMinhu ChenShenghong Zhang. (2019) Mucosal Healing Is Associated With the Reduced Disabling Disease in Crohn's Disease. Clinical and Translational Gastroenterology 10:3, pages e00015.
Crossref
Crossref
Shigeyoshi Yasukawa, Toshiyuki Matsui, Yutaka Yano, Yuho Sato, Yasumichi Takada, Masahiro Kishi, Yoichiro Ono, Noritaka Takatsu, Takashi Nagahama, Takashi Hisabe, Fumihito Hirai, Kenshi Yao, Toshiharu Ueki, Daijiro Higashi, Kitaro Futami, Suketo Sou, Toshihiro Sakurai, Tsuneyoshi Yao, Hiroshi Tanabe, Akinori Iwashita & Masakazu Washio. (2018) Crohn’s disease-specific mortality: a 30-year cohort study at a tertiary referral center in Japan. Journal of Gastroenterology 54:1, pages 42-52.
Crossref
Crossref
A Hillary Steinhart, Remo Panaccione, Laura Targownik, Brian Bressler, Reena Khanna, John K Marshall, Waqqas Afif, Charles N Bernstein, Alain Bitton, Mark Borgaonkar, Usha Chauhan, Brendan Halloran, Jennifer Jones, Erin Kennedy, Grigorios I Leontiadis, Edward V LoftusJrJr, Jonathan Meddings, Paul Moayyedi, Sanjay Murthy, Sophie Plamondon, Greg Rosenfeld, David Schwartz, Cynthia H Seow & Chadwick Williams. (2019) Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto Consensus. Inflammatory Bowel Diseases 25:1, pages 1-13.
Crossref
Crossref
Kelly C Cushing, Richard Mclean, Keely G McDonald, Jenny K Gustafsson, Kathryn A Knoop, Devesha H Kulkarni, R Balfour Sartor & Rodney D Newberry. (2019) Predicting Risk of Postoperative Disease Recurrence in Crohn’s Disease: Patients With Indolent Crohn’s Disease Have Distinct Whole Transcriptome Profiles at the Time of First Surgery. Inflammatory Bowel Diseases 25:1, pages 180-193.
Crossref
Crossref
Ho-Su Lee & Isabelle Cleynen. 2019. Molecular Genetics of Inflammatory Bowel Disease. Molecular Genetics of Inflammatory Bowel Disease
157
182
.
Anne S. Strik, Toer W. Stevens & Geert R. D’Haens. 2019. Biomarkers in Inflammatory Bowel Diseases. Biomarkers in Inflammatory Bowel Diseases
45
53
.
Zsuzsanna Kurti, Zsuzsanna Vegh, Lorant Gonczi & Peter L. Lakatos. 2019. Biomarkers in Inflammatory Bowel Diseases. Biomarkers in Inflammatory Bowel Diseases
9
22
.
A Hillary Steinhart, Remo Panaccione, Laura Targownik, Brian Bressler, Reena Khanna, John K Marshall, Waqqas Afif, Charles N Bernstein, Alain Bitton, Mark Borgaonkar, Usha Chauhan, Brendan Halloran, Jennifer Jones, Erin Kennedy, Grigorios I Leontiadis, Edward V LoftusJrJr, Jonathan Meddings, Paul Moayyedi, Sanjay Murthy, Sophie Plamondon, Greg Rosenfeld, David Schwartz, Cynthia H Seow & Chadwick Williams. (2018) Clinical Practice Guideline for the Medical Management of Perianal
Fistulizing Crohn’s Disease: The Toronto Consensus. Journal of the Canadian Association of Gastroenterology 1:4, pages 141-154.
Crossref
Crossref
Nadia Pallotta, Giuseppina Vincoli, Patrizio Pezzotti, Maurizio Giovannone, Alessandro Gigliozzi, Danilo Badiali, Piero Vernia & Enrico Stefano Corazziari. (2018) A risk score system to timely manage treatment in Crohn’s disease: a cohort study. BMC Gastroenterology 18:1.
Crossref
Crossref
Ashwin N Ananthakrishnan. (2018) Making sense of clinical predictors. Journal of Gastroenterology and Hepatology 33:S3, pages 7-8.
Crossref
Crossref
Claire Liefferinckx & Denis Franchimont. (2018) Viewpoint: Toward the Genetic Architecture of Disease Severity in Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 24:7, pages 1428-1439.
Crossref
Crossref
Denise Herzog, Nicolas Fournier, Patrick Buehr, Vanessa Rueger, Rebekka Koller, Klaas Heyland, Andreas Nydegger, Johannes Spalinger, Susanne Schibli, Laetitia-Marie Petit & Christian P. Braegger. (2018) Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications. European Journal of Gastroenterology & Hepatology 30:6, pages 598-607.
Crossref
Crossref
Cláudia Camila Dias, Francisco Portela, Samuel Fernandes, Paula Ministro, Paula Lago, Isadora Rosa, Luis Correia & Fernando Magro. (2018) The timing of early therapeutic strategies has a significant impact on Crohn’s disease prognosis. Digestive and Liver Disease 50:5, pages 462-468.
Crossref
Crossref
Corey A Siegel, Cynthia B Whitman, Brennan M R Spiegel, Brian Feagan, Bruce Sands, Edward V LoftusJrJr, Remo Panaccione, Geert D'Haens, Charles N Bernstein, Richard Gearry, Siew C Ng, Gerassimos J Mantzaris, Balfour Sartor, Mark S Silverberg, Robert Riddell, Ioannis E Koutroubakis, Colm O'Morain, Peter L Lakatos, Dermot P B McGovern, Jonas Halfvarson, Walter Reinisch, Gerhard Rogler, Wolfgang Kruis, Curt Tysk, Stefan Schreiber, Silvio Danese, William Sandborn, Anne Griffiths, Bjorn Moum, Christoph Gasche, Francesco Pallone, Simon Travis, Julian Panes, Jean-Frederic Colombel, Stephen Hanauer & Laurent Peyrin-Biroulet. (2018) Development of an index to define overall disease severity in IBD. Gut 67:2, pages 244-254.
Crossref
Crossref
Wei Liu, Wei Zhou, Jianjian Xiang, Qian Cao, Jinzhou Zhu, Weilin Qi, Pengpeng Chen & Qingwen Xie. (2018) Lémann Index at Diagnosis Predicts the Risk of Early Surgery in Crohn’s Disease. Diseases of the Colon & Rectum 61:2, pages 207-213.
Crossref
Crossref
Mahesh Gajendran, Priyadarshini Loganathan, Anthony P. Catinella & Jana G. Hashash. (2018) A comprehensive review and update on Crohn's disease. Disease-a-Month 64:2, pages 20-57.
Crossref
Crossref
Leonardo Guizzetti, Guangyong Zou, Reena Khanna, Parambir S Dulai, William J Sandborn, Vipul Jairath & Brian G Feagan. (2018) Development of Clinical Prediction Models for Surgery and Complications in Crohn’s Disease. Journal of Crohn's and Colitis 12:2, pages 167-177.
Crossref
Crossref
Mathurin Flamant & Xavier Roblin. (2018) Inflammatory bowel disease: towards a personalized medicine. Therapeutic Advances in Gastroenterology 11, pages 1756283X1774502.
Crossref
Crossref
Marcel Vetter & Markus F. Neurath. (2018) Treatment Perspectives in Crohn’s Disease. Digestion 98:3, pages 135-142.
Crossref
Crossref
Aida Kapic Lunder, Jørgen Jahnsen, Linda Tøften Bakstad, Arne Borthne, Johannes Roksund Hov, Morten Vatn, Anne Negård, Bjørn Moum, Inger Camilla Solberg, Tomm Bernklev, Ole Høie, Magne Henriksen, Marte Lie Høivik, Øistein Hovde, Gert Huppertz-Hauss & Iril Monstad. (2018) Bowel Damage in Patients With Long-term Crohn’s Disease, Assessed by Magnetic Resonance Enterography and the Lémann Index. Clinical Gastroenterology and Hepatology 16:1, pages 75-82.e5.
Crossref
Crossref
Nabeel Khan, Dhruvan Patel, Yash Shah, Chinmay Trivedi & Yu-Xiao Yang. (2017) Albumin as a prognostic marker for ulcerative colitis. World Journal of Gastroenterology 23:45, pages 8008-8016.
Crossref
Crossref
Toshifumi Hibi, Remo Panaccione, Miiko Katafuchi, Kaoru Yokoyama, Kenji Watanabe, Toshiyuki Matsui, Takayuki Matsumoto, Simon Travis & Yasuo Suzuki. (2017) The 5C Concept and 5S Principles in Inflammatory Bowel Disease Management. Journal of Crohn's and Colitis 11:11, pages 1302-1308.
Crossref
Crossref
Sarah Fischer & Markus F. Neurath. (2017) Precision Medicine in Inflammatory Bowel Diseases. Clinical Pharmacology & Therapeutics 102:4, pages 623-632.
Crossref
Crossref
Reena Khanna, Vipul Jairath & Brian G. Feagan. (2017) The Evolution of Treatment Paradigms in Crohn's Disease. Gastroenterology Clinics of North America 46:3, pages 661-677.
Crossref
Crossref
Yoo Min Han, Jaemoon Koh, Ji Won Kim, Changhyun Lee, Seong-Joon Koh, ByeongGwan Kim, Kook Lae Lee, Jong Pil Im & Joo Sung Kim. (2017) NF-kappa B activation correlates with disease phenotype in Crohn’s disease. PLOS ONE 12:7, pages e0182071.
Crossref
Crossref
Yehyun Park, Jae Hee Cheon, Yi Lang Park, Byong Duk Ye, You Sun Kim, Dong Soo Han, Joo Sung Kim, Sung Noh Hong, Young Ho Kim, Seong Ran Jeon & Won Ho Kim. (2017) Development of a Novel Predictive Model for the Clinical Course of Crohnʼs Disease. Inflammatory Bowel Diseases 23:7, pages 1071-1079.
Crossref
Crossref
Nabeel Khan, Dhruvan Patel, Yash Shah, Gary Lichtenstein & Yu-Xiao Yang. (2017) A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis. Inflammatory Bowel Diseases 23:6, pages 991-997.
Crossref
Crossref
Salvador Pous-Serrano, Matteo Frasson, Elena Cerrillo, Belén Beltrán, Marisa Iborra, David Hervás, Eduardo García-Granero & Pilar Nos. (2017) Correlation between fecal calprotectin and inflammation in the surgical specimen of Crohn's disease. Journal of Surgical Research 213, pages 290-297.
Crossref
Crossref
Eun Hye Oh, Kyunghwan Oh, Minkyu Han, Hyungil Seo, Kiju Chang, Sun-Ho Lee, Gwang-Un Kim, Eun Mi Song, Myeongsook Seo, Ho-Su Lee, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang & Byong Duk Ye. (2017) Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn’s disease with poor prognostic factors. PLOS ONE 12:5, pages e0177479.
Crossref
Crossref
James Irwin, Emma Ferguson, Lisa A. Simms, Katherine Hanigan, Franck Carbonnel & Graham Radford-Smith. (2017) A rolling phenotype in Crohn's disease. PLOS ONE 12:4, pages e0174954.
Crossref
Crossref
Zicheng Huang, Kang Chao, Miao Li, Min Zhi, Jian Tang, Pinjin Hu & Xiang Gao. (2017) Methotrexate for Refractory Crohnʼs Disease Compared with Thiopurines. Inflammatory Bowel Diseases 23:3, pages 440-447.
Crossref
Crossref
Julajak Limsrivilai, Ryan W. Stidham, Shail M. Govani, Akbar K. Waljee, Wen Huang & Peter D.R. Higgins. (2017) Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases. Clinical Gastroenterology and Hepatology 15:3, pages 385-392.e2.
Crossref
Crossref
Umar Darr & Nabeel Khan. (2017) Treat to Target in Inflammatory Bowel Disease: An Updated Review of Literature. Current Treatment Options in Gastroenterology 15:1, pages 116-125.
Crossref
Crossref
Cláudia Camila Dias, Pedro Pereira Rodrigues, Samuel Fernandes, Francisco Portela, Paula Ministro, Diana Martins, Paula Sousa, Paula Lago, Isadora Rosa, Luis Correia, Paula Moura Santos & Fernando Magro. (2017) The risk of disabling, surgery and reoperation in Crohn’s disease – A decision tree-based approach to prognosis. PLOS ONE 12:2, pages e0172165.
Crossref
Crossref
Fernando Magro, Cláudia C. Dias, Rosa Coelho, Paula M. Santos, Samuel Fernandes, Cidalina Caetano, Ângela Rodrigues, Francisco Portela, Ana Oliveira, Paula Ministro, Eugénia Cancela, Ana I. Vieira, Rita Barosa, José Cotter, Pedro Carvalho, Isabelle Cremers, Daniel Trabulo, Paulo Caldeira, Artur Antunes, Isadora Rosa, Joana Moleiro, Paula Peixe, Rita Herculano, Raquel Gonçalves, Bruno Gonçalves, Helena Tavares Sousa, Luís Contente, Henrique Morna & Susana Lopes. (2017) Impact of Early Surgery and Immunosuppression on Crohnʼs Disease Disabling Outcomes. Inflammatory Bowel Diseases 23:2, pages 289-297.
Crossref
Crossref
Giorgia Bodini, Edoardo G. Giannini, Costanza De Maria, Pietro Dulbecco, Manuele Furnari, Elisa Marabotto, Vincenzo Savarino & Edoardo Savarino. (2017) Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn’s disease. A study performed using the Lémann Index. Digestive and Liver Disease 49:2, pages 175-180.
Crossref
Crossref
Jae Jun ParkSuk-Kyun YangByong Duk YeJong Wook KimDong Il ParkHyuk YoonJong Pil ImKang Moon LeeSang Nam YoonHeeyoung Lee. (2017) Second Korean guidelines for the management of Crohn's disease. Intestinal Research 15:1, pages 38.
Crossref
Crossref
Jae Jun ParkSuk-Kyun YangByong Duk YeJong Wook KimDong Il ParkHyuk YoonJong Pil ImKang Moon LeeSang Nam YoonHeeyoung Lee. (2017) Second Korean Guidelines for the Management of Crohn's Disease. The Korean Journal of Gastroenterology 69:1, pages 29.
Crossref
Crossref
Julian Panes, Vipul Jairath & Barrett G. Levesque. (2017) Advances in Use of Endoscopy, Radiology, and Biomarkers to Monitor Inflammatory Bowel Diseases. Gastroenterology 152:2, pages 362-373.e3.
Crossref
Crossref
Florian Rieder, Claudio Fiocchi & Gerhard Rogler. (2017) Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases. Gastroenterology 152:2, pages 340-350.e6.
Crossref
Crossref
Jean-Frederic Colombel, Neeraj Narula & Laurent Peyrin-Biroulet. (2017) Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases. Gastroenterology 152:2, pages 351-361.e5.
Crossref
Crossref
Mark Silverberg & Sarah O’Donnell. 2017. Inflammatory Bowel Disease. Inflammatory Bowel Disease
29
44
.
Jacques Cosnes & Harry Sokol. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
653
660
.
Christine Y. Yu & Daniel W. Hommes. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
481
489
.
Jan-Michael A. Klapproth & Gary R. Lichtenstein. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
357
365
.
Joana Torres, Flavio Caprioli, Konstantinos H. Katsanos, Triana Lobatón, Dejan Micic, Marco Zerôncio, Gert Van Assche, James C. Lee, James O. Lindsay, David T. Rubin, Remo Panaccione & Jean-Frédéric Colombel. (2016) Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases. Journal of Crohn's and Colitis 10:12, pages 1385-1394.
Crossref
Crossref
Fernando T. Veloso. (2016) Clinical predictors of Crohn’s disease course. European Journal of Gastroenterology & Hepatology 28:10, pages 1122-1125.
Crossref
Crossref
Cláudia Camila Dias, Pedro Pereira Rodrigues, Rosa Coelho, Paula Moura Santos, Samuel Fernandes, Paula Lago, Cidalina Caetano, Ângela Rodrigues, Francisco Portela, Ana Oliveira, Paula Ministro, Eugénia Cancela, Ana Isabel Vieira, Rita Barosa, José Cotter, Pedro Carvalho, Isabelle Cremers, Daniel Trabulo, Paulo Caldeira, Artur Antunes, Isadora Rosa, Joana Moleiro, Paula Peixe, Rita Herculano, Raquel Gonçalves, Bruno Gonçalves, Helena Tavares Sousa, Luís Contente, Henrique Morna, Susana Lopes & Fernando Magro. (2016) Development and Validation of Risk Matrices for Crohn’s Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions. Journal of Crohn's and Colitis, pages jjw171.
Crossref
Crossref
Monica Cesarini, Gary S. Collins, Anders Rönnblom, Antonieta Santos, Lai Mun Wang, Daniel Sjöberg, Miles Parkes, Satish Keshav & Simon P. L. Travis. (2016) Predicting the Individual Risk of Acute Severe Colitis at Diagnosis. Journal of Crohn's and Colitis, pages jjw159.
Crossref
Crossref
Florian Rieder, Giovanni Latella, Fernando Magro, Elif S. Yuksel, Peter D. R. Higgins, Antonio Di Sabatino, Jessica R. de Bruyn, Jordi Rimola, Jorge Brito, Dominik Bettenworth, Gert van Assche, Willem Bemelman, Andre d’Hoore, Gianluca Pellino & Axel U. Dignass. (2016) European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease. Journal of Crohn's and Colitis 10:8, pages 873-885.
Crossref
Crossref
Aranzazu Jauregui Amezaga & Gert Van Assche. (2016) Practical Approaches to “Top–Down” Therapies for Crohn’s Disease. Current Gastroenterology Reports 18:7.
Crossref
Crossref
Vijaya L. Rao, Dejan Micic & Karen E. Kim. (2016) Primary Care Evaluation and Management of Gastroenterologic Issues in Women. Obstetrics and Gynecology Clinics of North America 43:2, pages 347-366.
Crossref
Crossref
Berkeley N. Limketkai, Alyssa M. Parian, Neha D. Shah & Jean-Frédéric Colombel. (2016) Short Bowel Syndrome and Intestinal Failure in Crohnʼs Disease. Inflammatory Bowel Diseases 22:5, pages 1209-1218.
Crossref
Crossref
Tomer Greener, Eyal Klang, Doron Yablecovitch, Adi Lahat, Sandra Neuman, Nina Levhar, Benjamin Avidan, Henit Yanai, Iris Dotan, Yehuda Chowers, Batya Weiss, Fred Saibil, Marianne M. Amitai, Shomron Ben-Horin, Uri Kopylov & Rami Eliakim. (2016) The Impact of Magnetic Resonance Enterography and Capsule Endoscopy on the Re-classification of Disease in Patients with Known Crohn’s Disease: A Prospective Israeli IBD Research Nucleus (IIRN) Study. Journal of Crohn's and Colitis 10:5, pages 525-531.
Crossref
Crossref
Mirthe E. van der Valk, Marie-Josée J. Mangen, Mirjam Severs, Mike van der Have, Gerard Dijkstra, Ad A. van Bodegraven, Herma H. Fidder, Dirk J. de Jong, C. Janneke van der Woude, Mariëlle J. L. Romberg-Camps, Cees H. M. Clemens, Jeroen M. Jansen, Paul C. van de Meeberg, Nofel Mahmmod, Andrea E. van der Meulen-de Jong, Cyriel Y. Ponsioen, Clemens Bolwerk, J. Reinoud Vermeijden, Peter D. Siersema, Max Leenders & Bas Oldenburg. (2016) Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up. PLOS ONE 11:4, pages e0142481.
Crossref
Crossref
P. Malmborg & H. Hildebrand. (2015) The emerging global epidemic of paediatric inflammatory bowel disease – causes and consequences. Journal of Internal Medicine 279:3, pages 241-258.
Crossref
Crossref
Laurent Peyrin-Biroulet, Julián Panés, William J. Sandborn, Séverine Vermeire, Silvio Danese, Brian G. Feagan, Jean-Frédéric Colombel, Stephen B. Hanauer & Beth Rycroft. (2016) Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions. Clinical Gastroenterology and Hepatology 14:3, pages 348-354.e17.
Crossref
Crossref
Elisa Liverani. (2016) How to predict clinical relapse in inflammatory bowel disease patients. World Journal of Gastroenterology 22:3, pages 1017.
Crossref
Crossref
Marta Mazza, Maria Giovanna Cilluffo & Maria Cappello. 2016. Crohn’s Disease. Crohn’s Disease
7
14
.
Lauri Arnstein. (2015) Achieving Treatment Goals in Inflammatory Bowel Disease: The Role of Gut-Selective Therapy. EMJ Gastroenterology, pages 40-49.
Crossref
Crossref
Devendra Desai. (2015) Disease Behaviour in Patients with Crohn’s Disease: A Review. Gastroenterology & Hepatology: Open Access 3:2.
Crossref
Crossref
Chang Mo Moon, Sung-Ae Jung, Seong-Eun Kim, Hyun Joo Song, Yunho Jung, Byong Duk Ye, Jae Hee Cheon, You Sun Kim, Young-Ho Kim, Joo Sung Kim & Dong Soo Han. (2015) Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn’s Disease Patients: Results from the CONNECT Study. PLOS ONE 10:12, pages e0144390.
Crossref
Crossref
Younjeong Choi, Seong-Joon Koh, Hee Sook Lee, Ji Won Kim, Byeong Gwan Kim, Kook Lae Lee & Joo Sung Kim. (2015) Roxithromycin inhibits nuclear factor kappaB signaling and endoplasmic reticulum stress in intestinal epithelial cells and ameliorates experimental colitis in mice. Experimental Biology and Medicine 240:12, pages 1664-1671.
Crossref
Crossref
Gil Y. Melmed & Stephan R. Targan. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
1418
1449
.
Peter L. Lakatos, Nora Sipeki, Gyorgy Kovacs, Eszter Palyu, Gary L. Norman, Zakera Shums, Petra A. Golovics, Barbara D. Lovasz, Peter Antal-Szalmas & Maria Papp. (2015) Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn’s Disease. Journal of Crohn's and Colitis 9:10, pages 891-898.
Crossref
Crossref
A Jauregui-Amezaga, J Rimola, I Ordás, S Rodríguez, A Ramírez-Morros, M Gallego, M C Masamunt, J Llach, B González-Suárez, E Ricart & J Panés. (2015) Value of endoscopy and MRI for predicting intestinal surgery in patients with Crohn's disease in the era of biologics. Gut 64:9, pages 1397-1402.
Crossref
Crossref
Olga Niewiadomski, Corrie Studd, Chris Hair, Jarrad Wilson, Nik S Ding, Neel Heerasing, Alvin Ting, John McNeill, Ross Knight, John Santamaria, Emily Prewett, Paul Dabkowski, Damian Dowling, Sina Alexander, Ben Allen, Benjamin Popp, William Connell, Paul Desmond & Sally Bell. (2015) Prospective population‐based cohort of inflammatory bowel disease in the biologics era: Disease course and predictors of severity. Journal of Gastroenterology and Hepatology 30:9, pages 1346-1353.
Crossref
Crossref
Michael Vieth, Raja Atreya & Helmut Neumann. (2015) Carcinoma in inflammatory bowel disease: endoscopic advances, management, and specimen handling. A review for the pathologist. Diagnostic Histopathology 21:7, pages 290-298.
Crossref
Crossref
Carolina Palmela, Joana Torres & Marilia Cravo. (2015) New Trends in Inflammatory Bowel Disease. GE Portuguese Journal of Gastroenterology 22:3, pages 103-111.
Crossref
Crossref
Markus F. Neurath. 2015. Mucosal Immunology. Mucosal Immunology
1613
1635
.
Liliana Oliveira. 2015. Inflammatory Bowel Disease. Inflammatory Bowel Disease
53
58
.
Darina Kohoutova, Marcela Drahosova, Paula Moravkova, Stanislav Rejchrt & Jan Bures. (2014) Anti-Outer membrane protein C and anti-glycoprotein 2 antibodies in inflammatory bowel disease and their association with complicated forms of Crohn’s disease. BMC Gastroenterology 14:1.
Crossref
Crossref
N. Khan & R. M. Almukhtar. (2014) Letter: predictors of severe disease in ulcerative colitis - the same or different in Crohn's disease? Authors' reply. Alimentary Pharmacology & Therapeutics 40:9, pages 1121-1122.
Crossref
Crossref
M. Barreiro-de-Acosta & J. P. Gisbert. (2014) Letter: predictors of severe disease in ulcerative colitis - the same or different in Crohn′s disease?. Alimentary Pharmacology & Therapeutics 40:9, pages 1120-1121.
Crossref
Crossref
Sofia Moco, Marco Candela, Emil Chuang, Colleen Draper, Ornella Cominetti, Ivan Montoliu, Denis Barron, Martin Kussmann, Patrizia Brigidi, Paolo Gionchetti & Francois-Pierre J. Martin. (2014) Systems Biology Approaches for Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:11, pages 2104-2114.
Crossref
Crossref
Thomas Billiet, Marc Ferrante & Gert Van Assche. (2014) The Use of Prognostic Factors in Inflammatory Bowel Diseases. Current Gastroenterology Reports 16:11.
Crossref
Crossref
Claudia Ott, Angela Takses, Florian Obermeier, Elisabeth Schnoy, Bernd Salzberger & Martina Müller. (2014) How fast up the ladder? Factors associated with immunosuppressive or anti-TNF therapies in IBD patients at early stages: results from a population-based cohort. International Journal of Colorectal Disease 29:11, pages 1329-1338.
Crossref
Crossref
David F. Schaeffer, Joanna C. Walsh, Richard Kirsch, Matti Waterman, Mark S. Silverberg & Robert H. Riddell. (2014) Distinctive histopathologic phenotype in resection specimens from patients with Crohn’s disease receiving anti–TNF-α therapy. Human Pathology 45:9, pages 1928-1935.
Crossref
Crossref
N. H. Khan, R. M. Almukhtar, E. B. Cole & A. M. Abbas. (2014) Early corticosteroids requirement after the diagnosis of ulcerative colitis diagnosis can predict a more severe long‐term course of the disease – a nationwide study of 1035 patients. Alimentary Pharmacology & Therapeutics 40:4, pages 374-381.
Crossref
Crossref
M. Prager & C. Büning. (2014) Klinik, CRP, Calprotectin, MRT oder Endoskopie?Clinical symptoms, C-reactive protein, calprotectin, MRI or endoscopy?. coloproctology 36:4, pages 250-258.
Crossref
Crossref
Ophélie Antunes, Jérôme Filippi, Xavier Hébuterne & Laurent Peyrin-Biroulet. (2014) Treatment algorithms in Crohn's – Up, down or something else?. Best Practice & Research Clinical Gastroenterology 28:3, pages 473-483.
Crossref
Crossref
Paulo Freire, Ricardo Cardoso, Pedro Figueiredo, Maria M. Donato, Manuela Ferreira, Sofia Mendes, Ana Margarida Ferreira, Helena Vasconcelos, Francisco Portela & Carlos Sofia. (2014) NOD2 gene mutations in ulcerative colitis: useless or misunderstood?. International Journal of Colorectal Disease 29:6, pages 653-661.
Crossref
Crossref
Mark E. Gerich & Dermot P. B. McGovern. (2013) Towards personalized care in IBD. Nature Reviews Gastroenterology & Hepatology 11:5, pages 287-299.
Crossref
Crossref
Séverine Vermeire, Marc Ferrante & Paul Rutgeerts. (2014) Republished: Recent advances: personalised use of current Crohn’s disease therapeutic options. Postgraduate Medical Journal 90:1061, pages 144-148.
Crossref
Crossref
Marilia Cravo, Paula Ferreira, Patricia Sousa, Paula Moura-Santos, Sonia Velho, Lurdes Tavares, João Ramos Deus, Paula Ministro, João Pereira da Silva, Luis Correia, Jose Velosa, Rui Maio & Miguel Brito. (2014) Clinical and genetic factors predicting response to therapy in patients with Crohn's disease. United European Gastroenterology Journal 2:1, pages 47-56.
Crossref
Crossref
David Rampton. (2014) Are Maintenance Strategies Underused in Crohn's Disease?. Digestive Diseases 32:4, pages 399-402.
Crossref
Crossref
Jose-Manuel Benitez & Edouard Louis. (2014) Can We Predict the High-Risk Patient?. Digestive Diseases 32:4, pages 328-336.
Crossref
Crossref
Chang Mo Moon, Dong Il Park, Eun Ran Kim, Young‐Ho Kim, Chang Kyun Lee, Suck‐Ho Lee, Jae Hak Kim, Kyu‐Chan Huh, Sung‐Ae Jung, Soon Man Yoon, Hyun Joo Song, Hyun Joo Jang, You Sun Kim, Kang‐Moon Lee & Jeong Eun Shin. (2013)
Clinical features and predictors of clinical outcomes in
K
orean patients with
C
rohn's disease: A
K
orean
A
ssociation for the
S
tudy of
I
ntestinal
D
iseases multicenter study
. Journal of Gastroenterology and Hepatology 29:1, pages 74-82.
Crossref
Crossref
Inger C. Solberg, Milada Cvancarova, Morten H. Vatn & Bjørn Moum. (2014) Risk Matrix for Prediction of Advanced Disease in a Population-based Study of Patients with Crohnʼs Disease (the IBSEN Study). Inflammatory Bowel Diseases 20:1, pages 60-68.
Crossref
Crossref
Vera Nina Götz. (2013) Crohn's disease—What the medical registrar and acute physician needs to know!. Journal of Acute Medicine 3:4, pages 132-137.
Crossref
Crossref
Yamile Zabana, Esther Garcia-Planella, Manuel van Domselaar, Míriam Mañosa, Jordi Gordillo, Antonio López-Sanromán, Eduard Cabré & Eugeni Domènech. (2013) Predictors of favourable outcome in inflammatory Crohn's disease. A retrospective observational study. Gastroenterología y Hepatología 36:10, pages 616-623.
Crossref
Crossref
Isabelle Cleynen, Juan R González, Carolina Figueroa, Andre Franke, Dermot McGovern, Martin Bortlík, Bart J A Crusius, Maurizio Vecchi, Marta Artieda, Magdalena Szczypiorska, Johannes Bethge, David Arteta, Edgar Ayala, Silvio Danese, Ruud A van Hogezand, Julian Panés, Salvador Amado Peña, Milan Lukas, Derek P Jewell, Stefan Schreiber, Severine Vermeire & Miquel Sans. (2013) Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project. Gut 62:11, pages 1556-1565.
Crossref
Crossref
Venkata S. Akshintala, Susan M. Hutfless, Dhiraj Yadav, Mouen A. Khashab, Anne Marie Lennon, Martin A. Makary, Kenzo Hirose, Dana K. Andersen, Anthony N. Kalloo & Vikesh K. Singh. (2013) A Population-Based Study of Severity in Patients With Acute on Chronic Pancreatitis. Pancreas 42:8, pages 1245-1250.
Crossref
Crossref
Séverine Vermeire, Marc Ferrante & Paul Rutgeerts. (2013) Recent advances: personalised use of current Crohn's disease therapeutic options. Gut 62:10, pages 1511-1515.
Crossref
Crossref
W. Kruis, A. Katalinic, T. Klugmann, G.-R. Franke, J. Weismüller, L. Leifeld, S. Ceplis-Kastner, B. Reimers & B. Bokemeyer. (2013) Predictive factors for an uncomplicated long-term course of Crohn's disease: A retrospective analysis. Journal of Crohn's and Colitis 7:7, pages e263-e270.
Crossref
Crossref
Florian Rieder, Ellen M Zimmermann, Feza H Remzi & William J Sandborn. (2013) Crohn's disease complicated by strictures: a systematic review. Gut 62:7, pages 1072-1084.
Crossref
Crossref
Michael C. Sulz, Uwe Siebert, Marjan Arvandi, Raffaella M. Gothe, Johannes Wurm, Roland von Känel, Stephan R. Vavricka, Christa Meyenberger & Markus Sagmeister. (2013) Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 25:7, pages 790-797.
Crossref
Crossref
Soo-Kyung Park, Suk-Kyun Yang, Seong Ho Park, Sang Hyoung Park, Jong Wook Kim, Dong-Hoon Yang, Kee Wook Jung, Kyung Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Chang Sik Yu & Jin-Ho Kim. (2013) Long-term Prognosis of the Jejunal Involvement of Crohn’s Disease. Journal of Clinical Gastroenterology 47:5, pages 400-408.
Crossref
Crossref
M. Prager & C. Büning. (2013) Klinik, CRP, Calprotectin, MRT oder Endoskopie?Clinical symptoms, C-reactive protein, calprotectin, MRI or endoscopy?. Der Gastroenterologe 8:3, pages 187-196.
Crossref
Crossref
Ioannis E KoutroubakisMathurin FumeryJean-Louis DupasPierre Desreumaux. 2013. Advances in the Management of Inflammatory Bowel Disease. Advances in the Management of Inflammatory Bowel Disease
158
172
.
José Luis Cabriada, Isabel Vera, Eugeni Domènech, Manuel Barreiro-de Acosta, María Esteve, Javier P. Gisbert, Julia Panés & Fernando Gomollón. (2013) Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa sobre el uso de fármacos antifactor de necrosis tumoral α en la enfermedad inflamatoria intestinal (2013). Gastroenterología y Hepatología 36:3, pages 127-146.
Crossref
Crossref
P. B. Allen, M. A. Kamm, L. Peyrin‐Biroulet, C. Studd, C. Mc Dowell, B. C. M. Allen, W. R. Connell, P. P. De Cruz, S. J. Bell, R. P. Elliot, S. Brown, P. V. Desmond, M. Lemann & J.‐F. Colombel. (2012)
Development and validation of a patient‐reported disability measurement tool for patients with
inflammatory bowel disease
. Alimentary Pharmacology & Therapeutics 37:4, pages 438-444.
Crossref
Crossref
Rute Maria Cerqueira & Paula M. Lago. (2013) Clinical factors predictive of Crohn’s disease complications and surgery. European Journal of Gastroenterology & Hepatology 25:2, pages 129-134.
Crossref
Crossref
Isabelle Cleynen & Séverine Vermeire. 2013. Molecular Genetics of Inflammatory Bowel Disease. Molecular Genetics of Inflammatory Bowel Disease
151
169
.
Guillaume Savoye, Julia Salleron, Corinne Gower-Rousseau, Jean-Louis Dupas, Gwénola Vernier-Massouille, Mathurin Fumery, Véronique Merle, Eric Lerebours, Antoine Cortot, Dominique Turck, Jean-Louis Salomez, Marc Lemann, Jean-Frédéric Colombel & Alain Duhamel. (2012) Clinical predictors at diagnosis of disabling pediatric Crohnʼs disease. Inflammatory Bowel Diseases 18:11, pages 2072-2078.
Crossref
Crossref
Crispin Corte, Payal Saxena, Stephen Tattersall, Christian Selinger & Rupert W Leong. (2012) When to use biological agents in inflammatory bowel disease. Journal of Gastroenterology and Hepatology 27:7, pages 1141-1149.
Crossref
Crossref
Severine Vermeire, Gert Van Assche & Paul Rutgeerts. (2012) Classification of inflammatory bowel disease. Current Opinion in Gastroenterology 28:4, pages 321-326.
Crossref
Crossref
Wojciech Blonski, Anna M. Buchner & Gary R. Lichtenstein. (2012) Clinical Predictors of Aggressive/Disabling Disease: Ulcerative Colitis and Crohn Disease. Gastroenterology Clinics of North America 41:2, pages 443-462.
Crossref
Crossref
Jatinder P. Ahluwalia. (2012) Immunotherapy in Inflammatory Bowel Disease. Medical Clinics of North America 96:3, pages 525-544.
Crossref
Crossref
J. R. Goodhand, N. Kamperidis, N. M. Joshi, M. Wahed, Y. Koodun, E. J. Cantor, N. M. Croft, F. L. Langmead, J. O. Lindsay & D. S. Rampton. (2012)
The phenotype and course of inflammatory bowel disease in
UK
patients of
B
angladeshi descent
. Alimentary Pharmacology & Therapeutics 35:8, pages 929-940.
Crossref
Crossref
Adam V. Weizman & Mark S. Silverberg. (2012) Have Genomic Discoveries in Inflammatory Bowel Disease Translated into Clinical Progress?. Current Gastroenterology Reports 14:2, pages 139-145.
Crossref
Crossref
Peter De Cruz, Michael A. Kamm, Lani Prideaux, Patrick B. Allen & Paul V. Desmond. (2012) Postoperative recurrent luminal Crohnʼs Disease: A systematic review. Inflammatory Bowel Diseases 18:4, pages 758-777.
Crossref
Crossref
Esther Garcia-Planella, Míriam Mañosa, Manuel Van Domselaar, Jordi Gordillo, Yamile Zabana, Eduard Cabré, Antonio López San Román & Eugeni Domènech. (2012) Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids. Digestive and Liver Disease 44:3, pages 206-210.
Crossref
Crossref
Edouard Louis, Daniel C. Baumgart, Subrata Ghosh, Fernando Gomollón, Stephen Hanauer, Ailsa Hart & Peter Irving. (2012) What changes in inflammatory bowel disease management can be implemented today?. Journal of Crohn's and Colitis 6, pages S260-S267.
Crossref
Crossref
Byong Duk YeSuk-Kyun YangSung Jae ShinKang Moon LeeByung Ik JangJae Hee CheonChang Hwan ChoiYoung-Ho KimHeeyoung Lee. (2012) Guidelines for the Management of Crohn's Disease. Intestinal Research 10:1, pages 26.
Crossref
Crossref
Byong Duk Ye, Suk-Kyun YangSung Jae ShinKang Moon LeeByung Ik JangJae Hee Cheon, Chang Hwan ChoiYoung-Ho KimHeeyoung Lee. (2012) Guidelines for the Management of Crohn's Disease. The Korean Journal of Gastroenterology 59:2, pages 141.
Crossref
Crossref
Jacques Cosnes, Harry Sokol & Philippe Seksik. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
713
725
.
Anne Christine W. Vos & Daniel W. Hommes. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
535
547
.
Yoav Mazor, Itay Maza, Eduard Kaufman, Shomron Ben-Horin, Amir Karban, Yehuda Chowers & Rami Eliakim. (2011) Prediction of disease complication occurrence in Crohn's disease using phenotype and genotype parameters at diagnosis. Journal of Crohn's and Colitis 5:6, pages 592-597.
Crossref
Crossref
Michael A. Kamm, Siew C. Ng, Peter De Cruz, Patrick Allen & Stephen B. Hanauer. (2011) Practical application of anti-TNF therapy for luminal Crohnʼs disease. Inflammatory Bowel Diseases 17:11, pages 2366-2391.
Crossref
Crossref
Rafael J.A. Cámara, Alain M. Schoepfer, Valérie Pittet, Stefan Begré & Roland von Känel. (2011) Mood and nonmood components of perceived stress and exacerbation of Crohnʼs disease. Inflammatory Bowel Diseases 17:11, pages 2358-2365.
Crossref
Crossref
James C. Lee, Paul A. Lyons, Eoin F. McKinney, John M. Sowerby, Edward J. Carr, Francesca Bredin, Hannah M. Rickman, Huzefa Ratlamwala, Alexander Hatton, Tim F. Rayner, Miles Parkes & Kenneth G.C. Smith. (2011) Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis. Journal of Clinical Investigation 121:10, pages 4170-4179.
Crossref
Crossref
K. Elriz, V. Palascak-Juif, F. Joly, D. Seguy, P. Beau, C. Chambrier, M. Boncompain, E. Fontaine, D. Laharie, G. Savoye & E. Lerebours. (2011) Crohn’s disease patients with chronic intestinal failure receiving long-term parenteral nutrition: a cross-national adult study. Alimentary Pharmacology & Therapeutics 34:8, pages 931-940.
Crossref
Crossref
Marc Ferrante & S′everine Vermeire. 2011. Clinical Dilemmas in Inflammatory Bowel Disease. Clinical Dilemmas in Inflammatory Bowel Disease
117
119
.
Displaying 200 of 227 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list